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ABSTRACT
Staphylococcus aureus isolates (n = 30) from the environment or from surgical patients in a hospital in
Guangzhou, China were investigated for the presence of class 1 integrons. The class 1 integrase (intI1)
gene and its 3¢ conserved segment were detected by PCR. IntI1-positive isolates were further analysed
for the presence of resistance gene cassettes using speciﬁc primers, intI1-K and In-B. All isolates were
also subjected to multilocus sequence typing (MLST) and random ampliﬁed polymorphic DNA (RAPD)-
PCR analysis. Sixteen (53%) clinical and environmental isolates were positive for the class 1 integrase
gene and were also found to possess the aadA2 gene. The 30 isolates were classiﬁed into six distinct
genotypes by RAPD-PCR analysis: type A (n = 2); type B (n = 2); type C (n = 3); type D (n = 7); type E
(n = 8); and type F (n = 8). All isolates belonged to the same sequence type (ST239) by MLST. These
results indicated transmission of S. aureus between the environment and patients, as well as the
probability of nosocomial infection.
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INTRODUCTION
Indiscriminate use of existing antibiotics has
resulted in the proliferation of antibiotic resist-
ance and posed a dilemma for the future treat-
ment of bacterial infection. Several mechanisms
involving mobile genetic elements, e.g., plasmids
and transposons, have been shown to contribute
to the spread of antibiotic resistance genes among
bacteria. In addition, the role of integrons in
the spread of antibiotic resistance has become
well-established [1–3]. An integron comprises a
number of elements, including an integrase gene
(intI), a recombination site (attI) and a promoter
gene. Several classes of integrons have been
described, based on the intI gene, with classes
1–3 forming so-called multiresistance integrons.
Of these, class 1 integrons are the most ubiquitous
type among resistant clinical isolates of Gram-
negative bacteria, and are associated with the
Tn21 transposon family [4,5]. Class 1 integrons
can capture gene cassettes, which contain an attC
recombination site, via a site-speciﬁc recombina-
tion event between attI and attC. The 3¢ conserved
segment (3¢CS) of integrons contains the qacED1
and sul1 genes, encoding resistance to quaternary
ammonium salts and sulphonamides, respect-
ively [6]. Although the role of class 1 integrons
in the spread of antibiotic resistance genes among
Gram-negative bacteria is clear, little is known
about the prevalence of class 1 integrons in Gram-
positive bacteria, especially in Staphylococcus au-
reus [7,8], in which antibiotic resistance has
become a great concern.
S. aureus is one of the most prevalent pathogens
in hospitals. Since this organism can spread easily
by direct or indirect contact between patients and
the environment, or among patients and medical
personnel, S. aureus is an important cause of
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nosocomial infection, and major outbreaks are
common [9,10]. Such infections pose a challenge
for clinicians, hospital epidemiologists and
administrators, since they may lead to serious
therapeutic and infection control problems [11].
The objective of the present study was to
detect and characterise class 1 integrons present
among isolates of S. aureus from the environment
and from patients in a surgical ward of a
hospital in China. Multilocus sequencing typing
(MLST) and random ampliﬁed polymorphic
DNA (RAPD)-PCR analyses were performed to
investigate the clonal relationships among the
isolates.
MATERIALS AND METHODS
Clinical setting and data collection
Between March and May 2005, 30 S. aureus isolates (Table 1)
were obtained from patients and the environment at Guang-
dong Provincial Peoples’ Hospital (Guangzhou, China), a
2052-bed tertiary-level teaching hospital, during active sur-
veillance of patients colonised or infected with S. aureus. A
tracking log was used to identify epidemiological relatedness
among patients in order to select isolates for testing and thus
document epidemiological clusters. Repeat isolates were
excluded. According to CDC deﬁnitions of nosocomial
infection [12], only the ﬁrst isolate obtained from cultures
performed >48 h after admission was included in the analy-
sis. Vibrio cholerae O1 strain SK-10 and Escherichia coli strain
C600 were used as positive and negative controls, respectively,
for the intI1 gene [13].
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was performed using a
standard disk-diffusion method according to CLSI guidelines
[14]. Susceptibility to oxacillin, amoxycillin–clavulanic acid,
cefuroxime, ciproﬂoxacin, chloramphenicol, clindamycin,
erythromycin, gentamicin, rifampicin, trimethoprim–sulpha-
methoxazole, tetracycline, vancomycin, teicoplanin, spectino-
mycin and streptomycin was determined as described previ-
ously [15]. S. aureus strains ATCC 25923 and ATCC 29213
were used as controls.
Template DNA preparation
Template DNA from S. aureus isolates was prepared from
Luria–Bertani broth cultures grown overnight at 37C with
aeration. Each culture was diluted ten-fold in 10 mM Tris-HCl
(pH 8.0) and 1 mM EDTA, boiled for 10 min and kept subse-
quently on ice. After centrifugation at 12 000 g for 3 min, the
resulting supernatant was used as the template for PCR assays.
PCR ampliﬁcation of class 1 integrase, variable regions
and 3¢CS
All S. aureus isolates were examined by PCR, for the intI1
gene using primers intI1-U (5¢-GTTCGGTCAAGGTTCTG)
and intI1-D (5¢-GCCAACTTTCAGCACATG) as described
Table 1. Clinical data for Staphylococcus aureus isolates from patients and the environment in the surgical ward
Isolate Source Isolation date RAPD type ST intI1 Gene cassette Resistance pattern
050555 E (rinse solution) 2005.5.26 A 239 – AMC, CHL, CIP, CLI, ERY, GEN, OXA, TET, TS
050556 C (nasal cavity) 2005.5.26 A 239 – AMC, CHL, CIP, CLI, ERY, GEN, OXA, TET, TS
050584 C (nasal cavity) 2005.5.30 B 239 – AMC, CHL, CIP, ERY, OXA, TET, TS
050586 E (parenteral solution) 2005.5.30 B 239 – AMC, CHL, CIP ERY, OXA, TET, TS
042242 C (stool) 2005.4.1 C 239 – AMC, CHL, CIP, ERY, OXA, TET, TS
042243 C (pus) 2005.4.1 C 239 – AMC, CHL, CIP, ERY, OXA, TET, TS
042244 C (blood) 2005.4.1 C 239 – AMC, CHL, CIP, ERY, OXA, TET, TS
032120 E (rinse solution) 2005.3.26 D 239 – ACM, CHL, CIP, CHL, ERY, GEN, OXA, TET, TS
032121 C (sputum) 2005.3.26 D 239 – AMC, CHL, CIP, CLI, ERY, GEN, OXA, TET, TS
032133 C (blood) 2005.3.27 D 239 – AMC, CHL, CIP, CLI, ERY, GEN, OXA, TET, TS
032142 C (sputum) 2005.3.30 D 239 – AMC, CHL, CIP, CLI, ERY, GEN, OXA, TET, TS
032145 C (sputum) 2005.3.31 D 239 – AMC, CHL, CIP, CLI, ERY, GEN, OXA, TET, TS
032146 C (blood) 2005.3.31 D 239 – AMC, CHL, CIP, CLI, ERY, GEN, OXA, TET, TS
050485 E (rinse solution) 2005.5.14 D 239 – AMC, CHL, CIP, CLI, ERY, GEN, OXA, TET, TS
050557 C (nasal cavity) 2005.5.26 E 239 + aadA2 AMC, CHL, CIP, CLI, ERY, GEN, OXA, TET, STR, SPT, TS
050558 C (jugular vein) 2005.5.26 E 239 + aadA2 AMC, CHL, CIP, CLI, ERY, GEN, OXA, TET, STR, SPT, TS
050561 C (nasal cavity) 2005.5.27 E 239 + aadA2 AMC, CHL, CIP, CLI, ERY, GEN, OXA, TET, STR, SPT, TS
050562 C (nasal cavity) 2005.5.27 E 239 + aadA2 AMC, CHL, CIP, CLI, ERY, GEN, OXA, TET, STR, SPT, TS
050581 E (parenteral solution) 2005.5.30 E 239 + aadA2 AMC, CHL, CIP, CLI, ERY, GEN, OXA, TET, STR, SPT, TS
050582 C (nasal swab) 2005.5.30 E 239 + aadA2 AMC, CHL, CIP, CLI, ERY, GEN, OXA, TET, STR, SPT, TS
050583 C (nasal cavity) 2005.5.30 E 239 + aadA2 AMC, CHL, CIP, CLI, ERY, GEN, OXA, TET, STR, SPT, TS
050585 C (nasal cavity) 2005.5.30 E 239 + aadA2 AMC, CHL, CIP, CLI, ERY, GEN, OXA, TET, STR, SPT, TS
032147 E (console) 2005.3.31 F 239 + aadA2 AMC, CHL, CIP, CLI, ERY, GEN, OXA, TET, STR, SPT, TS
032148 E (door handle) 2005.3.31 F 239 + aadA2 AMC, CHL, CIP, CLI, ERY, GEN, OXA, TET, STR, SPT, TS
050511 E (rinse solution) 2005.5.19 F 239 + aadA2 AMC, CHL, CIP, CLI, ERY, GEN, OXA, TET, STR, SPT, TS
050512 E (tracheal intubation) 2005.5.19 F 239 + aadA2 AMC, CHL, CIP, CLI, ERY, GEN, OXA, TET, STR, SPT, TS
050513 C (nasal mucus) 2005.5.19 F 239 + aadA2 AMC, CHL, CIP, CLI, ERY, GEN, OXA, TET, STR, SPT, TS
050518 C (sputum) 2005.5.20 F 239 + aadA2 AMC, CHL, CIP, CLI, ERY, GEN, OXA, TET, STR, SPT, TS
050559 C (nasal cavity) 2005.5.27 F 239 + aadA2 AMC, CHL, CIP, CLI, ERY, GEN, OXA, TET, STR, SPT, TS
050560 C (nasal cavity) 2005.5.27 F 239 + aadA2 AMC, CHL, CIP, CLI, ERY, GEN, OXA, TET, STR, SPT, TS
RAPD, random ampliﬁed polymorphic DNA; ST, sequence type; E, isolated from environment; C, isolated from clinical specimen; AMC, amoxycillin–clavulanic acid; CHL,
chloramphenicol; CIP, ciproﬂoxacin; CLI, clindamycin; ERY, erythromycin; GEN, gentamicin; OXA, oxacillin; STR, streptomycin; SPT, spectinomycin; TET, tetracycline; TS,
trimethoprim–sulphamethoxazole.
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previously [16]. Ampliﬁcation of the variable region between
the intI1 gene and the 3¢CS of class 1 integrons was performed
using primers intI1-K (5¢-ACCGAAACCTTGCGCTCGT) and
In-B (5¢-AAGCAGACTTGACCTGAT) and the following
touchdown program: 94C for 4 min, ten touchdown cycles
of 94C for 1 min, 62C for 30 s (decreasing by 1C ⁄ cycle)
and 72C for 2 min, followed by 24 cycles of 30 s at 94C,
30 s at 52C and 2 min at 72C, with a ﬁnal extension for
7 min at 72C (GeneAmp PCR System ABI 2700; Applied
Biosystems, Tokyo, Japan). Class 1 integrase-positive iso-
lates were also tested for the 3¢CS region using primers
qacED1-F (5¢-ATCGCAATAGTTGGCGAAGT) and sul1-B
(5¢-GCAAGGCGGAAACCCGCGCC) as described previously
[16].
Cloning and sequencing of the variable region
PCR amplicons of the intI1 gene and the variable region were
puriﬁed from agarose gels and ligated with the pGEM-T
easy vector (Promega, Madison, WI, USA). The ligation
mixture was transformed into E. coli DH5a and recombinants
were selected on Luria agar containing ampicillin
(100 mg ⁄L). Recombinant plasmid DNA was puriﬁed by
standard methods and subjected to sequencing and further
analyses. The nucleotide sequences of the insert DNA were
determined using the BigDye Terminator Cycle Sequencing
FS Ready Reaction Kit on an ABI PRISM 310 Genetic Ana-
lyzer (Applied Biosystems). The nucleotide sequences were
analysed and compared with sequences in GenBank using
the BLAST algorithm (http://www.ncbi.nlm.nih.gov). The
nucleotide sequence of the antibiotic resistance gene cassette
has been deposited in GenBank under accession no.
AB253625.
MLST
MLST was performed as described previously [17], targeting
the internal regions of seven housekeeping genes: arc, aroE,
glpF, gmk, pta, tpi and yqiL. Amplicons were sequenced and
compared with the MLST database for S. aureus (http://
www.mlst.net), and the allelic number was determined for
each sequence. The sequence type (ST) was determined
according to the pattern of the combination of the seven
alleles, and the clonal complex was deﬁned by the BURST
(based upon related sequence types) program on the MLST
website.
DNA ﬁngerprinting analysis by RAPD-PCR analysis
All S. aureus isolates were analysed by RAPD-PCR using
primers KZ (5¢-CCCATGTGTACGCGTGTGGG) and M13
(5¢-GGAAACAGCTATGACCATG) as described previously
[9]. The resulting PCR products were electrophoresed on
agarose 1.2% w ⁄v gels, and this was followed by ethidium
bromide staining for 10 min and documentation using the Gel
Doc EQ system (Bio-Rad, Hercules, CA, USA). Analysis was
performed using Quantity One v.4.5 software (Bio-Rad). The
similarity of ﬁngerprints was calculated using the Dice
coefﬁcient. Cluster analysis was performed using the
unweighted pair-group method with arithmetic averages
(UPGMA). Isolates with RAPD patterns that had more than one
band difference in terms of size or intensity were considered to
be distinct types.
RESULTS
Antimicrobial resistance phenotypes
Antimicrobial susceptibility testing revealed that
all 30 isolates were multiresistant (i.e., resistant to
at least seven of the antimicrobial agents tested),
and could be classiﬁed into three groups accord-
ing to their susceptibility proﬁle (Table 1). The
MIC of oxacillin ranged from 16 to 512 mg ⁄L.
None of the isolates tested showed resistance to
vancomycin and teicoplanin.
Detection of class 1 integrons and
characterisation of the variable region
Sixteen (53%) isolates yielded a 923-bp PCR
product, and the resulting DNA sequences had
100% identity with the intI1 gene sequenced
previously (GenBank accession no. Y18050). All
of these intI1-positive isolates produced an
800-bp amplicon in the 3¢CS PCR, indicating
the presence of the complete class 1 integron
structure. Eleven of these 16 isolates were
from clinical sources (Table 1). In addition, an
1800-bp product was ampliﬁed from all 16
isolates using primer set intI1-K and in-B. Nuc-
leotide sequence analysis revealed that this frag-
ment contained a partial intI1 gene, an attI site
and a 975-bp open reading frame harbouring an
aadA2 gene cassette encoding resistance to ami-
noglycosides.
MLST
All 30 isolates shared the same allelic proﬁle
(2-3-1-1-4-4-3), corresponding to that of ST239,
which is the most prevalent ST among S. aureus
isolates in China and other Asian countries except
Japan and Korea [18].
DNA ﬁngerprinting by RAPD-PCR analysis
RAPD-PCR yielded a complex banding pattern,
consisting of four to nine fragments ranging in
size from 0.3 to 4.0 kb. The DNA ﬁngerprints
were clustered by UPGMA analysis using the Dice
coefﬁcient (Fig. 1). The gene cassette results and
the DNA ﬁngerprints indicated that some isolates
which carried aadA2 and belonged to the same
genotype were representative of speciﬁc clones
found at the hospital. As shown in Table 1, 14
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isolates belonging to types A, B, C and D were
integron-negative, while the other 16 isolates,
belonging to types E and F, carried a class 1
integron with the aadA2 gene cassette.
Four isolates (050557, 0505558, 050561 and
050562) belonging to type E were obtained from
clinical specimens on consecutive days, with
isolates 050557, 050558 and 050561 being obtained
from patients in adjacent beds. Isolates 050581
(from the environment), 050582, 050583 and 050585
were obtained on the same day. Among type F
isolates, 032147, 032148, 050511 and 050512 were
from the environment, while 050513, 050518,
050559 and 050560 were from clinical specimens.
DISCUSSION
Since class 1 integrons were ﬁrst described by
Stokes and Hall in 1989 [19], integron-mediated
resistance to antibiotics has been reported in
clinical isolates of various Gram-negative bacteria
[20–23]. Integrons have been identiﬁed as a
primary source of resistance genes, and are
suspected to form reservoirs of antimicrobial
resistance genes within microbial populations
[19,24]. However, with few exceptions, most of
these studies have been performed with Gram-
negative bacteria [1,4,7,8]. In the present study of
30 S. aureus isolates, seven environmental and
nine clinical isolates were found to carry class 1
integrons that contained intI1, the attI site, an
aadA2 gene cassette and the 3¢CS.
This is, to our knowledge, the ﬁrst report of
class 1 integrons in nosocomial S. aureus. Class 1
integrons are known to spread among Gram-
negative bacteria, and a class I integron carried on
a plasmid has been transferred from an Entero-
coccus faecalis strain to a recipient strain of
Ent. faecalis [7]. In the present study, the class 1
integron containing the aadA2 gene was identical
to that found in Gram-negative bacteria [1–6,13].
Further studies are required to investigate
whether class 1 integrons can spread between
Gram-positive and Gram-negative bacteria.
The present study showed a good correlation
among the clustering results based on antimi-
crobial susceptibility testing, the presence of a
class 1 integron, and RAPD-PCR ﬁngerprint
analysis. According to antimicrobial susceptibil-
ity testing, the 30 isolates could be classiﬁed into
three groups. All isolates carrying a class 1
integron had the same antibiogram, with addi-
tional resistance to spectinomycin and strepto-
mycin, while integron-negative isolates were
susceptible to aminoglycosides (Table 1).
According to RAPD-PCR analysis, the 30 isolates
belonged to six distinct types. Even though all
the isolates belonged to the same ST, there seems
to be considerable genotypic variation within
this ST.
The presence of S. aureus is a risk-factor for
nosocomial and community-acquired infections,
and nosocomial infection caused by antibiotic-
resistant S. aureus has been a growing problem in
the surgical ward. The present study identiﬁed
clonally related isolates from the environment
and from patients, indicating transmission
between the two. S. aureus environmental con-
tamination is probably the most important factor
in nosocomial infection [24], with many potential
reservoirs of S. aureus in the hospital environ-
ment.
In conclusion, to our knowledge, this is the ﬁrst
study to report the occurrence of clinical and
environmental isolates of S. aureus that carry
a class 1 integron containing the aadA2 gene
cassette. Clonally related isolates carrying the
class 1 integron continued to be isolated from
patients and the environment over a 2-month
period.
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Fig. 1. Representative random ampliﬁed polymorphic
DNA patterns of Staphylococcus aureus isolates and their
genetic relatedness.
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